LifeMD, Inc. (LFMD) Tops Q3 EPS by 17c ; Offers Guidance

LifeMD, Inc. (NASDAQ: LFMD) reported Q3 EPS of $0.08, $0.17 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.6 million versus the consensus estimate of $38.16 million.

GUIDANCE:

LifeMD, Inc. sees Q4 2023 revenue of $40-41 million, versus the consensus of $41.34 million.

LifeMD, Inc. sees FY2023 revenue of $148-149 million, versus the consensus of $148.6 million.

For earnings history and earnings-related data on LifeMD, Inc. (LFMD) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Equinor ASA (ADR) (EQNR) PT Lowered to $37 at TD Cowen
• Visteon (VC) PT Raised to $135 at TD Cowen